Ian F. Tannock

Researcher Next ID · RN-004272

Researcher · Medicine

Toronto, Canada

Not currently recruitingFunding unknown

Research interests

Medicine

Mathematics

Biochemistry, Genetics and Molecular Biology

Prostate Cancer Treatment and Research

Prostate Cancer Diagnosis and Treatment

Statistical Methods in Clinical Trials

Cancer-related cognitive impairment studies

Cancer, Hypoxia, and Metabolism

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju124
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.12.4487
Drug Resistance and the Solid Tumor Microenvironment
JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djm135
Drug penetration in solid tumours
Nature reviews. Cancer · 2006 · https://doi.org/10.1038/nrc1893
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa040720

No projects listed.